Table of Contents
Used if fibrinogen is low (<1g/L) and there is active bleeding, e.g. in:
Used for patients at risk of severe CMV disease:
Used to prevent transfusion-associated graft vs. host disease in severely immunocompromised:
NB: in an emergency, there will not be time to crossmatch blood, so O negative (or non-crossmatched group-specific blood) may be used.